- Kutzsche J, Schemmert S, Bujnicki T, Zafiu C, Halbgebauer S, Kraemer-Schulien V, Pils M, Blömeke L, Post J, Kulawik A, Jürgens D, Rossberg WM, Hümpel M, Bannach O, Otto M, Araujo JA, Willuweit A, Willbold D.
Oral treatment with the all-d-peptide RD2 enhances cognition in aged beagle dogs - A model of sporadic Alzheimer's disease
Heliyon 29;9(8):e18443, (2023)
https://pubmed.ncbi.nlm.nih.gov/37609390/
- Kulawik A,Heise H,Zafiu C,Willbold D,Bannach O.
Advancements of the sFIDA method for oligomer-based diagnostics of neurodegenerative diseases
FEBS Letters , (2018)
http://onlinelibrary.wiley.com/doi/10.1002/1873-3468.12983/abstract
CLICK
- Herrmann Y, Bujnicki T, Zafiu C, Kulawik A, Kühbach K, Peters L, Fabig J, Willbold J, Bannach O, Willbold D.
Nanoparticle standards for immuno-based quantitation of α-synuclein oligomers in diagnostics of Parkinson's disease and other synucleinopathies.
Clin Chim Acta 466, 152–159 (2017)
http://dx.doi.org/10.1016/j.cca.2017.01.010
http://www.sciencedirect.com/science/article/pii/S0009898117300104
- Herrmann Y, Kulawik A, Kühbach K, Hülsemann M, Peters L, Bujnicki T, Kravchenko K, Linnartz C, Willbold J, Zafiu C, Bannach O, Willbold D.
sFIDA automation yields sub-femtomolar limit of detection for Aβ aggregates in body liquids.
Clinical Biochem. 50(4-5), 244-247 (2017)
http://dx.doi.org/10.1016/j.clinbiochem.2016.11.001
http://www.sciencedirect.com/science/article/pii/S0009912016305008
- Kravchenko K, Kulawik A, Hülsemann M, Kühbach K, Zafiu C, Herrmann Y, Linnartz C, Peters L, Bujnicki T, Willbold J, Bannach O, Willbold D.
Analysis of anticoagulants for blood-based quantitation of amyloid β oligomers in the sFIDA assay.
Biol. Chem. 398(4), 465-475 (2017)
https://dx.doi.org/10.1515/hsz-2016-0153
https://www.degruyter.com/view/j/bchm.ahead-of-print/hsz-2016-0153/hsz-2016-0153.xml
- Kühbach K, Hülsemann M, Herrmann Y, Kravchenko K, Kulawik A, Linnartz C, Peters L, Wang K, Willbold J, Willbold D, Bannach O.
Application of an amyloid beta oligomer standard in the sFIDA assay.
In: Biomarkers of Alzheimer's Disease: The Present and the Future. Eds. Sylvain Lehmann, Charlotte Elisabeth Teunissen. , 39-44 (2017)
ISBN 9782889450411
- Hülsemann M, Zafiu C, Kühbach K, Lühmann N, Herrmann Y, Peters L, Linnartz C, Willbold J, Kravchenko K, Kulawik A, Willbold S, Bannach O, Willbold D.
Biofunctionalized Silica Nanoparticles: Standards in Amyloid-β Oligomer-Based Diagnosis of Alzheimer's Disease.
J. Alzheimers Dis. 54, 79-88 (2016)
https://dx.doi.org/10.3233/JAD-160253
http://content.iospress.com/articles/journal-of-alzheimers-disease/jad160253
- Kühbach K, Hülsemann M, Herrmann Y, Kravchenko K, Kulawik A, Linnartz C, Peters L, Wang K, Willbold J, Willbold D, Bannach O.
Application of an Amyloid Beta Oligomer Standard in the sFIDA Assay
Front. Neurosci. 10:8, (2016)
http://dx.doi.org/10.3389/fnins.2016.00008
http://journal.frontiersin.org/article/10.3389/fnins.2016.00008
- Wördehoff MM, Bannach O, Shaykhalishahi H, Kulawik A, Schiefer S, Willbold D, Hoyer W, Birkmann E
Single fibril growth kinetics of alpha-synuclein.
J. Mol. Biol. 427, 1428-1435 (2015)
http://dx.doi.org/10.1016/j.jmb.2015.01.020
http://journal.frontiersin.org/article/10.3389/fnins.2016.00008/abstract
Responsible for the content: